Reubi JC - Search Results

1

Switch from antagonist to agonist after addition of a DOTA chelator to a somatostatin analog.

Reubi JC, Erchegyi J, Cescato R, Waser B, Rivier JE. Reubi JC, et al. Eur J Nucl Med Mol Imaging. 2010 Aug;37(8):1551-8. doi: 10.1007/s00259-010-1445-x. Epub 2010 Apr 16. Eur J Nucl Med Mol Imaging. 2010. PMID: 20396884 Free PMC article.

2

PEG spacers of different length influence the biological profile of bombesin-based radiolabeled antagonists.

Jamous M, Tamma ML, Gourni E, Waser B, Reubi JC, Maecke HR, Mansi R. Jamous M, et al. Among authors: reubi jc. Nucl Med Biol. 2014 Jul;41(6):464-70. doi: 10.1016/j.nucmedbio.2014.03.014. Epub 2014 Mar 29. Nucl Med Biol. 2014. PMID: 24780298

3

A new peptidic somatostatin agonist with high affinity to all five somatostatin receptors.

Reubi JC, Eisenwiener KP, Rink H, Waser B, Mäcke HR. Reubi JC, et al. Eur J Pharmacol. 2002 Dec 5;456(1-3):45-9. doi: 10.1016/s0014-2999(02)02651-1. Eur J Pharmacol. 2002. PMID: 12450568

4

Concomitant expression of several peptide receptors in neuroendocrine tumours: molecular basis for in vivo multireceptor tumour targeting.

Reubi JC, Waser B. Reubi JC, et al. Eur J Nucl Med Mol Imaging. 2003 May;30(5):781-93. doi: 10.1007/s00259-003-1184-3. Epub 2003 Apr 18. Eur J Nucl Med Mol Imaging. 2003. PMID: 12707737 Review.

5

Internalization of sst2, sst3, and sst5 receptors: effects of somatostatin agonists and antagonists.

Cescato R, Schulz S, Waser B, Eltschinger V, Rivier JE, Wester HJ, Culler M, Ginj M, Liu Q, Schonbrunn A, Reubi JC. Cescato R, et al. Among authors: reubi jc. J Nucl Med. 2006 Mar;47(3):502-11. J Nucl Med. 2006. PMID: 16513620 Free article.

6

Selective in vitro targeting of GRP and NMB receptors in human tumours with the new bombesin tracer 177Lu-AMBA.

Waser B, Eltschinger V, Linder K, Nunn A, Reubi JC. Waser B, et al. Among authors: reubi jc. Eur J Nucl Med Mol Imaging. 2007 Jan;34(1):95-100. doi: 10.1007/s00259-006-0229-9. Epub 2006 Aug 15. Eur J Nucl Med Mol Imaging. 2007. PMID: 16909223 Free article.

7

Radiolabeled somatostatin receptor antagonists are preferable to agonists for in vivo peptide receptor targeting of tumors.

Ginj M, Zhang H, Waser B, Cescato R, Wild D, Wang X, Erchegyi J, Rivier J, Mäcke HR, Reubi JC. Ginj M, et al. Among authors: reubi jc. Proc Natl Acad Sci U S A. 2006 Oct 31;103(44):16436-41. doi: 10.1073/pnas.0607761103. Epub 2006 Oct 20. Proc Natl Acad Sci U S A. 2006. PMID: 17056720 Free PMC article.

8

DOTA-PESIN, a DOTA-conjugated bombesin derivative designed for the imaging and targeted radionuclide treatment of bombesin receptor-positive tumours.

Zhang H, Schuhmacher J, Waser B, Wild D, Eisenhut M, Reubi JC, Maecke HR. Zhang H, et al. Among authors: reubi jc. Eur J Nucl Med Mol Imaging. 2007 Aug;34(8):1198-208. doi: 10.1007/s00259-006-0347-4. Epub 2007 Jan 30. Eur J Nucl Med Mol Imaging. 2007. PMID: 17262215 Free article.

9

Design and in vitro characterization of highly sst2-selective somatostatin antagonists suitable for radiotargeting.

Cescato R, Erchegyi J, Waser B, Piccand V, Maecke HR, Rivier JE, Reubi JC. Cescato R, et al. Among authors: reubi jc. J Med Chem. 2008 Jul 10;51(13):4030-7. doi: 10.1021/jm701618q. Epub 2008 Jun 11. J Med Chem. 2008. PMID: 18543899 Free PMC article.

10

Highly efficient in vivo agonist-induced internalization of sst2 receptors in somatostatin target tissues.

Waser B, Tamma ML, Cescato R, Maecke HR, Reubi JC. Waser B, et al. Among authors: reubi jc. J Nucl Med. 2009 Jun;50(6):936-41. doi: 10.2967/jnumed.108.061457. Epub 2009 May 14. J Nucl Med. 2009. PMID: 19443580 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

450 results

Search Page

Filters